← All transactions
BioSerenity: €15M Series B from LBO France, Bpifrance, Eurazeo
Exclusive advisor to the company
- Date
- Sept 2017
- Sector
- Healthcare
- Business
- Portable health monitoring
- Transaction
- €15M Series B from LBO France, Bpifrance, Eurazeo
- Apparius’s role
- Exclusive advisor to the company
- Area of focus
- Digital health and healthcare services
A developer of connected clothing for diagnosing conditions such as epilepsy, BioSerenity raised €15 million from LBO France (Innovation Capital), the PSIM fund managed by Bpifrance and its existing shareholder Idinvest Partners.